XML 54 R22.htm IDEA: XBRL DOCUMENT
v3.22.4

Business Combinations (Notes) | 12 Months Ended
--- | ---
Dec. 31, 2022
Business Combination and Asset Acquisition [Abstract] |
Business Combination Disclosure [Text Block] | Business Combinations On October 3, 2022, the Company acquired all of the outstanding common shares of Change Healthcare Inc. (Change) and funded Change’s payoff of its outstanding debt and credit facility for a total of $13.9 billion in cash. The combination of the Company and Change will connect and simplify the core clinical, administrative and payment processes health care providers and payers depend on to serve patients. Change brings key technologies, connections and advanced clinical decision, administrative and financial support capabilities, enabling better workflow and transactional connectivity across the health care system. Subsequent to closing and as planned, the Company sold Change’s claims editing business to an affiliate of investment funds of TPG Inc. for $2.2 billion in cash. The net assets and net liabilities associated with this sale were classified as held-for-sale at the time of acquisition. There was no gain or loss associated with this transaction. During the year ended December 31, 2022, the Company completed several other business combinations for total consideration of $8.8 billion. The Company also sold other businesses for $1.2 billion of cash, with a carrying value of $600 million, and the difference reflected in the Consolidated Statement of Operations. Acquired assets (liabilities) at acquisition date were:
(in millions) |  | Change |  | Other Acquisitions |  | Total
Cash and cash equivalents |  | $ | 222 |  |  | $ | 523 |  |  | $ | 745 |
Accounts receivable and other current assets |  | 925 |  |  | 696 |  |  | 1,621 |
Assets held-for-sale |  | 2,310 |  |  | — |  |  | 2,310 |
Property, equipment and other long-term assets |  | 254 |  |  | 1,882 |  |  | 2,136 |
Other intangible assets |  | 4,050 |  |  | 1,764 |  |  | 5,814 |
Total identifiable assets acquired |  | 7,761 |  |  | 4,865 |  |  | 12,626 |
Medical costs payable |  | — |  |  | (308) |  |  | (308) |
Accounts payable and other current liabilities |  | (1,017) |  |  | (843) |  |  | (1,860) |
Liabilities held-for-sale |  | (101) |  |  | — |  |  | (101) |
Other long-term liabilities |  | (1,193) |  |  | (713) |  |  | (1,906) |
Total identifiable liabilities acquired |  | (2,311) |  |  | (1,864) |  |  | (4,175) |
Total net identifiable assets |  | 5,450 |  |  | 3,001 |  |  | 8,451 |
Goodwill |  | 8,496 |  |  | 9,214 |  |  | 17,710 |
Redeemable noncontrolling interests |  | — |  |  | (3,108) |  |  | (3,108) |
Nonredeemable noncontrolling interests |  | — |  |  | (370) |  |  | (370) |
Net assets acquired |  | $ | 13,946 |  |  | $ | 8,737 |  |  | $ | 22,683 |
The majority of goodwill is not deductible for income tax purposes. The preliminary purchase price allocations for the various business combinations are subject to adjustment as valuation analyses, primarily related to intangible assets and contingent liabilities, are finalized. The acquisition date fair values and weighted-average useful lives assigned to finite-lived intangible assets acquired consisted of the following:
|  | Change |  | Other Acquisitions |  | Total
(in millions, except years) |  | Fair Value |  | Weighted-Average Useful Life |  | Fair Value |  | Weighted-Average Useful Life |  | Fair Value |  | Weighted-Average Useful Life
Customer-related |  | $ | 3,063 |  |  | 15 years |  | $ | 864 |  |  | 13 years |  | $ | 3,927 |  |  | 15 years
Trademarks and technology |  | 977 |  |  | 6 years |  | 81 |  |  | 4 years |  | 1,058 |  |  | 6 years
Other |  | 10 |  |  | 1 year |  | 766 |  |  | 13 years |  | 776 |  |  | 13 years
Total acquired finite-lived intangible assets |  | $ | 4,050 |  |  | 13 years |  | $ | 1,711 |  |  | 13 years |  | $ | 5,761 |  |  | 13 years
The results of operations and financial condition of acquired entities have been included in the Company’s consolidated results and the results of the corresponding operating segment as of the date of acquisition. Through December 31, 2022, acquired entities impact on revenues and net earnings was not material. Unaudited pro forma revenues and net earnings for the years ended December 31, 2022 and 2021, as if the business combinations had occurred on January 1, 2021, were immaterial for both periods.

X
- References No definition available. + Details
Name: | us-gaap_BusinessCombinationAndAssetAcquisitionAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable). + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -URI https://asc.fasb.org/topic&trid=2303972 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 5 -Subparagraph (b) -URI https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472 + Details
Name: | us-gaap_BusinessCombinationDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration